Cantharidin treatment can inhibit tumor cell proliferation and induce autophagy. Combination therapy with cantharidin and TRAIL may be a successful strategy for treating TRAIL-resistant prostate cancer. The gene discussed is TNFSF10; the disease is prostate carcinoma.